Clinical Trials Directory

Trials / Unknown

UnknownNCT01301261

Sugammadex: Effect on the Awareness Monitoring and Hemodynamics

The Effect of Sugammadex on Hemodynamics, Oxygenation, End-tidal CO2, Entropy and Bispectral Index Intraoperatively Without Steroid Neuromuscular Blocker

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
University of Athens · Academic / Other
Sex
All
Age
30 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Sugammadex is used to reverse the neuromuscular blocking effect of steroid neuromuscular blockers. Its cardiovascular effects and effect on brain cortex, if any, may be associated to the reversal of the neuromuscular block. The aim of the study was to investigate the pure effects of sugammadex in the absence of the agonist.

Detailed description

Three groups of patients undergoing elective major surgery and given cis-atracurium for muscle relaxation are studied. Group 1 receives 2 mg/kg of sugammadex when a count of two of the train of four appears Group 2 receives 4 mg/kg of sugammadex when a posttetanic count 1-3 appears Group 3 receives 16 mg/kg of sugammadex three minutes after administration of cis-atracurium. Heart rate, arterial blood pressure, oxygen saturation, end-tidal CO2, entropy and bispectral index are recorded every three minutes

Conditions

Interventions

TypeNameDescription
DRUGsugammadexSugammadex 2 mg/kg when a two count of train of four appears
DRUGSugammadex 4 mg/kgSugammadex 4 mg/kg are given when a posttetanic count 1-3 appears
DRUGSugammadex 16mg/kgSugammadex 16 mg/kg three minutes after the injection of cis-atracurium

Timeline

Start date
2010-12-01
Primary completion
2013-02-01
First posted
2011-02-23
Last updated
2012-06-19

Locations

1 site across 1 country: Greece

Source: ClinicalTrials.gov record NCT01301261. Inclusion in this directory is not an endorsement.